CRChristopher J. Russell

Christopher J. Russell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher J. Russell has a total of 147 co-authors. Here are the top co-authors by number of shared publications:

  • Michael N. Neely

    Pediatrics Children's Hospital Los Angeles Los Angeles California USA

    8 shared publications
  • Tamara D. Simon

    Pediatrics Children's Hospital Los Angeles Los Angeles California USA

    7 shared publications
  • Rebecca Steuart

    Section of Complex Care, Department of Pediatrics, Medical College of Wisconsin

    6 shared publications
  • Joanna Thomson

    Division of Hospital Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics University of Cincinnati College of Medicine Cincinnati Ohio USA

    5 shared publications
  • John Michael Morrison

    Division of Pediatric Hospital Medicine, Department of Pediatrics, John Hopkins All Children's Hospital, 501 6th Ave S, St. Petersburg, FL, USA

    5 shared publications
  • Abigail Woolums

    Department of Pediatrics University of Cincinnati College of Medicine Cincinnati Ohio USA

    4 shared publications

Latest Publications

  • Open Access

    Trauma center drug screening practices and equity in screening for injured adolescents

    by Jordan M. Rook, Whitney Orji, Jenna S. Lee, Ryan G. Spurrier, Arash Safavi, Christopher J. Russell, Shant Shekherdimian, Catherine Juillard, Lorraine I. Kelley-Quon

  • Open Access

    Longitudinal dynamics of respiratory microbiome composition in infants after new tracheostomy placement

    by Rebecca Steuart, Samantha N Atkinson, Lucas R Hoffman, Long Hung, Xiangming Ding, Nita Salzman, Christopher J Russell

    Objectives: This prospective longitudinal study characterised respiratory microbiome dynamics following new tracheostomy placement among infants. Setting: A tertiary care paediatric hospital system in the United States. Participants: Fifteen infants ≤12 months of age contributed 84 tracheal aspirate samples collected from day 1 through 3–4 months post-placement. Primary and secondary outcome measures: Bacterial composition, including abundance, from 16S rRNA gene sequencing; alpha and beta diversity measures over time. Results: 16S rRNA gene sequencing revealed immediate and sustained bacterial community shifts. Staphylococcus abundance increased and alpha diversity decreased in the first 30 days post-tracheostomy (p<0.05) before returning to baseline. Beta diversity demonstrated compositional changes immediately and with ongoing divergence through 3–4 months. Time and clinical factors (prematurity, ventilation and neurologic impairment) were significantly associated with microbiome structure (p=0.001). Conclusions: This study provides novel evidence that new tracheostomy placement induces rapid and prolonged airway microbiome disruption in infants, highlighting a previously uncharacterised window of vulnerability with implications for respiratory health.

  • Open Access

    Factors associated with discharge on higher respiratory support for children with tracheostomy hospitalized with bacterial tracheostomy‐associated infections: A prospective, multicenter cohort study

    by Krystal S. Jin, Naoko Kono, Jonathan D. Cogen, Sarah Hofman DeYoung, Catherine S. Forster, Andrea Hahn, Margaret Rush, John M. Morrison, Joanna E. Thomson, Sukhada V. Mairal, et al.

    We conducted a multicenter prospective cohort study to identify factors associated with discharge on higher respiratory support in children with tracheostomy hospitalized for bacterial tracheostomy‐associated infections (bTRAINs). We included children 0–21 years with tracheostomy hospitalized for bTRAIN at six freestanding children's hospitals between 2020 and 2024. The primary outcome was discharge on higher respiratory support compared to pre‐hospital baseline. Generalized linear mixed‐effects regression models accounted for patient and hospital clustering. We included 641 children representing 1180 hospitalizations, with a median age of 5 years; 45.9% were female, 35.6% Hispanic, and 20.0% Non‐Hispanic Black. 24.7% were discharged on higher respiratory support. In adjusted analyses, discharge on higher respiratory support was associated with increased oxygen requirement, escalation of chronic ventilator settings, acute ventilatory support, and longer length of stay. In our study, discharge on higher respiratory support was driven by illness severity, rather than demographic or home support factors.

  • Open Access

    Evaluating Antibiotic Treatment of Possible Bacterial Co‐Infection During Viral Illnesses in Children With Tracheostomies

    by Katarina Y. Manzi, Kawsar A. Hirsi, Naoko Kono, Teoman Toprak, Christopher J. Russell, Sarah C. Hofman DeYoung, Jonathan D. Cogen

  • Open Access

    Early Antibiotic Discontinuation for Children With a Positive Rapid Respiratory Viral Test Hospitalized for Suspected Bacterial Tracheostomy‐Associated Infections

    by Christopher J. Russell, Naoko Kono, Margaret Rush, Andrea Hahn, Catherine S. Forster, Jonathan D. Cogen, Sarah Hofman DeYoung, John M. Morrison, Joanna Thomson, Sukhada Vaidya Mairal, et al.

    Objective: Test the association between early antibiotic discontinuation and outcomes for children with a tracheostomy and positive respiratory viral PCR (RVP) hospitalized with suspected bTRAIN (bacterial TRacheostomy‐Associated INfection; pneumonia/tracheitis). Methods: We conducted a multicenter cohort study between September 1, 2021 and August 31, 2024 of children with pre‐existing tracheostomy hospitalized for suspected bTRAIN (tracheal aspirate bacterial culture sent and bTRAIN antibiotics started) at six children's hospitals with: (1) a positive RVP test; (2) no antibiotic pre‐treatment; and (3) length of stay (LOS) < 37 days (outlier). Mixed‐effects regression models identified independent associations between early antibiotic discontinuation and our primary outcome, LOS (in days). Inverse probability treatment weighting based on propensity scoring adjusted for measured confounding. We explored the association between early antibiotic discontinuation and 3 secondary outcomes: late ICU transfer, in‐hospital mortality, and 30‐day bTRAIN rehospitalization rates. Results: Of 542 hospitalizations in 365 children, the median admission age was 4 years (interquartile range [IQR]: 2–8 years). Common viruses included rhinovirus ( n = 282; 52%), SARS‐CoV‐2 ( n = 63; 12%), and respiratory syncytial virus ( n = 61; 11%). The median LOS was 7 days (IQR: 5–11 days). Only 28% ( n = 152) had early antibiotic discontinuation; full bTRAIN treatment was associated with a 23% (5%–45%) increased LOS, with estimated LOS means (95% CI) of 7.0 (5.8–8.4) days for early antibiotic discontinuation and 8.6 (7.8–9.4) days in the bTRAIN‐treated group. Secondary outcome rates (late ICU transfer = 14.6%; in‐hospital mortality = 0.9%; 30‐day bTRAIN rehospitalization rate = 8.3%) were similar rates between both groups. Conclusions: Given similar rates of serious outcomes in both groups, clinicians could consider early discontinuation of antibiotic treatment in children with suspected bTRAINs who have a positive RVP test.

  • Open Access

    Pediatric tracheostomy-associated respiratory infections: an evolving paradigm

    by John M. Morrison, Rebecca Steuart, Christopher J. Russell

    Purpose of review: Children with tracheostomy frequently experience tracheostomy-associated infections (TRAINs) such as pneumonia and tracheitis. This review will summarize current evidence regarding the diagnosis, treatment, and prevention of TRAINs. Recent findings: Recent evidence highlights limitations of respiratory culture testing in the face of a diverse, dynamic bacterial community within the airways of children with tracheostomy, challenging the notion that a positive bacterial culture is sufficient for diagnosing bacterial TRAIN. For this reason, recent consensus guidelines recommend against the routine obtainment of respiratory cultures for TRAIN diagnosis in the absence of specific clinical symptoms. Additional evidence for microbiome shifts and host inflammation as diagnostic tools may help identify those who will benefit from antibiotic treatment. Recent findings support selective anaerobic coverage when aspiration is suspected and suggest shorter antibiotic courses may be effective. Cycled inhaled tobramycin shows potential for reducing TRAIN frequency and related hospitalizations. Summary: With recent advances in TRAIN pathobiology, diagnosis, treatment, and prevention of TRAINs is undergoing a paradigm shift. Future translational research will define the airway microbiome during TRAINs and during wellness and its impact on host inflammation. Antibiotic clinical trials are needed to optimize treatment and prevention of TRAINs.


  • Open Access

    The child opportunity index and discharge disposition among children with new tracheostomy and long-term mechanical ventilation

    by Lindsey L Scheller, Abbey Alkon, Thomas J Hoffmann, Sandra Staveski, Carolyn C Foster, Christopher J Russell

    Rationale: Although discharge to home is the goal for many children on new long-term mechanical ventilation via tracheostomy (LTMV-T), families often face barriers to access, such as home health nursing. Disparities in discharge disposition and the impact of social determinants of health (SDOHs) remain understudied. Objective: To examine the association between neighborhood-level SDOHs and discharge disposition among children on new LMTV-T. Methods: This retrospective cohort study included children aged 0 to 18 years newly discharged with LTMV-T between 2014 and 2023 from 47 pediatric hospitals, using the Pediatric Health Information System database. The primary outcome was discharge disposition, defined as home or skilled facility. The primary exposure was the Child Opportunity Index (COI), a composite measure of neighborhood-level SDOHs, reported in quintiles (very low to very high opportunity). The association between COI and discharge disposition was evaluated using a multivariable mixed-effects logistic regression model with a random effect for hospitals and states. A mediation analysis was conducted to assess whether COI mediated racial and ethnic disparities in discharge disposition. Results: Of the 5042 eligible children, most were male (57%), covered by government insurance (61%), and non-Hispanic White (45%) and non-Hispanic Black (23%). Median length of stay was 148 days (IQR, 81-232 days), and median age at discharge was 10 months (IQR, 7-18 months). A total of 1011 (20%) children were discharged to a skilled facility, and 2554 (51%) lived in very low to low COI neighborhoods, with more than half of the non-Hispanic Black population living in very low to low COI neighborhoods. Compared to children from very high opportunity neighborhoods, children from very low COI (adjusted odds ratio [aOR] = 3.11; 95% CI, 2.30-4.21), low COI (aOR = 2.22; 95% CI, 1.63-3.02), moderate COI (aOR = 2.19; 95% CI, 1.60-2.99), and high COI (aOR = 1.65; 95% CI, 1.20-2.26) had increased odds of being discharged to skilled facility than home. Among non-Hispanic Black children, only 24% of the total effect between race/ethnicity and discharge disposition was mediated by COI. Conclusion: Disparities in institutionalization exist among children with LTMV-T from lower COI compared to very high COI neighborhoods. Addressing neighborhood-level conditions and implementing policies such as paid family caregiving or insurance reimbursement may reduce inequities in discharge disposition.


  • Open Access

    Longitudinal dynamics of respiratory microbiome composition in infants after tracheostomy placement

    by Rebecca Steuart, Samantha N. Atkinson, Lucas R. Hoffman, Long Hung, Xiangming Ding, Nita L. Salzman, Christopher J. Russell

    Abnormal respiratory microbiomes are reported in children with artificial airways, yet the timing and persistence of these disruptions have not been defined in infants following new tracheostomy placement. We conducted a prospective longitudinal study to characterize airway microbiome dynamics following new tracheostomy placement during early life, a critical period for microbiome development. Fifteen hospitalized infants <=12 months contributed 84 tracheal aspirate samples collected from day 1 through 3 to 4 months post-procedure. 16S rRNA sequencing revealed immediate and sustained community shifts. Staphylococcus abundance increased after tracheostomy, peaking at 40 days (mean 27%) before declining, with a more pronounced bloom in infants without home mechanical ventilation (HMV). Alpha diversity decreased significantly in the first 30 days (p<0.05) and returned to baseline by 61 to 90 days. Beta diversity analysis demonstrated marked compositional changes immediately post-tracheostomy and ongoing divergence through 3 to 4 months. Time since tracheostomy and clinical factors (gestational age, HMV, neurologic impairment) were significantly associated with microbiome structure (p=0.001). These findings provide novel evidence that tracheostomy induces rapid and prolonged airway microbiome disruption in infants, highlighting a previously uncharacterized window of vulnerability with implications for respiratory health and individualized care.

  • Open Access

    Comparing COVID-19 Variants in Children Hospitalized for Concern of Tracheostomy-associated Infection: A Multicenter Prospective Cohort Study

    by Ilana Moffet, Naoko Kono, Margaret Rush, Christopher J Russell, Andrea Hahn, Pediatric Research in Inpatient Settings Network

    In this ancillary study of a larger, prospective cohort study, we sought to compare presentation and outcomes of COVID-19 infections by variant (alpha, delta, and omicron) in 103 children with tracheostomy (108 admissions) hospitalized for concern of bacterial tracheostomy-associated infection. Dexamethasone use was significantly higher with delta compared to alpha (78% vs. 40%; OR, 5.5; P = 0.04). Increased oxygen (76%–89%) and ventilatory support during hospitalization (35-67%) were noted across all variants. Death occurred in 3%–6% of patients.

  • Factors associated with tracheostomy‐associated infection treatment: A multicenter observational study

    by John M. Morrison, Naoko Kono, Margaret Rush, Andrea Hahn, Catherine S. Forster, Jonathan D. Cogen, Joanna Thomson, Sarah Hofman DeYoung, Sowgand Bashiri, Wendy J. Mack, et al.

    Objective: To characterize factors that influence the decision to treat suspected pediatric bacterial tracheostomy‐associated respiratory infections (bTRAINs; e.g., pneumonia, tracheitis).Methods: We conducted a multicenter, prospective cohort study of children with pre‐existing tracheostomy hospitalized at six children's hospitals for a suspected bTRAIN (receipt of respiratory culture plus ≥1 doses of an antibiotic within 48 h). The primary predictor was respiratory culture growth categorized as Pseudomonas aeruginosa, P. aeruginosa + ≥1 other bacterium, other bacteria alone, or normal flora/no growth. Our primary outcome was bTRAIN treatment with a complete course of antibiotics as documented by the discharge team. We used logistic regression with generalized estimating equations to identify the association between our primary predictor and outcome and to identify demographic, clinical, and diagnostic testing factors associated with treatment.Results: Of the 440 admissions among 289 patients meeting inclusion criteria, 307 (69.8%) had positive respiratory culture growth. Overall, 237 (53.9%) of admissions resulted in bTRAIN treatment. Relative to a negative culture, a culture positive for P. aeruginosa plus ≥1 other organism (adjusted odds ratio [aOR] 2.3; 95% confidence interval [CI] 1.02–5.0)] or ≥1 other organism alone (aOR: 2.8; 95% CI: 1.4–5.6)] was associated with treatment. Several clinical and diagnostic testing (respiratory Gram‐stain and chest radiograph) findings were also associated with treatment. Positive respiratory viral testing was associated with reduced odds of treatment (aOR: 0.5; 95% CI: 0.2–0.9).Conclusions: Positive respiratory cultures as well as clinical indicators of acute illness and nonculture test results were associated with bTRAIN treatment. Clinicians may be more comfortable withholding antibiotics when a virus is identified during testing.